| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-10 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.21 | 8e-06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.2 | 2e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |